Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

Torsten Zuberbier, Riccardo Asero, Carsten Bindslev‐Jensen et al. · Allergy · 2009 · 708 citations · Full text

Life Sciences, Dermatology, Immunology +15

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Allen P. Kaplan, Dennis K. Ledford, Mark Ashby et al. · Journal of Allergy and Clinical Immunology · 2013 · 559 citations

Life Sciences, Immunology, Pharmacotherapy +11

EAACI/GA²LEN/EDF/WAO guideline: management of urticaria

Torsten Zuberbier, Riccardo Asero, Carsten Bindslev‐Jensen et al. · Allergy · 2009 · 523 citations

Life Sciences, Dermatology, Immunology +13

The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria

SABROE, Grattan, Francis et al. · British Journal of Dermatology · 1999 · 422 citations

Life Sciences, Dermatology, Immunology +16